Symbols

LFST

LifeStance Health·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

LFST fundamentals

LFST Q3 2025 Earnings

LifeStance Health (LFST) released its earnings on Nov 6, 2025: revenue was 363.81M (YoY +16.34%), beat estimates; EPS was 0 (YoY +100.00%), missed estimates.

Revenue / YoY

363.81M

+16.34%

EPS / YoY

+100.00%

Report date

Nov 6, 2025

LFST Earnings Call Summary for Q3,2025

Record Q3 Growth: 17% visit growth, $40M EBITDA (11% margin), and 288 new clinicians added.
Productivity Boost: 5% clinician productivity gains via AI tools and incentive programs.
Strategic Expansion: Calm partnership and specialty services (neuropsych testing, TMS) driving high-margin growth.
Financial Strength: Positive net income, and $204M cash balance support 2026 M&A and tech investments.
Risk Mitigation: Minimal government payer exposure (5% of revenue) and focus on commercial insurance.

Earnings

EPS

Revenue

Revenue & Expenses

LFST has released its 2025 Q3 earnings report, with revenue of 363.81M, reflecting a YoY change of 16.34%, and net profit of 1.08M, showing a YoY change of 118.08%. The Sankey diagram below clearly presents LFST's revenue sources and cost distribution.

Key Indicators

LifeStance Health (LFST) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

LifeStance Health (LFST)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

LifeStance Health (LFST)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

LifeStance Health (LFST)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown